Arthur M. Cohen & Associates, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Arthur M. Cohen & Associates, LLC

  • $551 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024
SELL
$902.69 - $993.35 $22,567 - $24,833
-25 Reduced 10.2%
220 $211,000
Q3 2023

Oct 20, 2023
BUY
$692.45 - $844.37 $169,650 - $206,870
245 New
245 $201,000
Q1 2023

Apr 24, 2023
BUY
$680.49 - $826.97 $166,720 - $202,607
245 New
245 $201,000

Others Institutions Holding REGN

# of Institutions
1,488
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Arthur M. Cohen & Associates, LLC Portfolio

Follow Arthur M. Cohen & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email